塞尔维斯特评分可能是预测非缺血性扩张型心肌病患者 ICD 治疗的指标。
Selvester Score May Be a Predictor of ICD Therapies in Patients with Non-Ischemic Dilated Cardiomyopathy.
机构信息
Department of Cardiology, Isparta Suleyman Demirel University, Faculty of Medicine, Isparta,Turkey.
Department of Cardiology, Kahramanmaras Sutcu Imam University, Faculty of Medicine, Kahramanmaras, Turkey.
出版信息
Braz J Cardiovasc Surg. 2022 Dec 1;37(6):900-907. doi: 10.21470/1678-9741-2021-0112.
INTRODUCTION
The benefit of implantable cardioverter-defibrillator (ICD) in patients with non-ischemic dilated cardiomyopathy (DCM) is still an issue under discussion. Studies examining the relationship between ventricular scar tissue and ICD shock with cardiac magnetic resonance (CMR) are promising. CMR studies have shown that ventricular scar tissue size and Selvester score show a correlation. In the light of this information, this study aimed to investigate the potential relationship between Selvester score and ICD therapies.
METHODS
The study included 48 patients who had undergone ICD implantation with a diagnosis of DCM and who had undergone routine 6-month ICD control in outpatient clinic controls between December 2018 and October 2019. Selvester score and other data were compared between patients who received ICD therapy (n=10) and those who did not (n=38).
RESULTS
Selvester score (P<0.001) was higher in ICD therapy group. Positive correlation was found between ICD shock therapy and Selvester score (P=0.002, r=0.843). Selvester score was detected as an independent predictor for ICD therapy after multiple linear regression analysis (P=0.004). Receiver operating characteristic curve analysis showed that Selvester score (P<0.001) was a significant predictor of ICD therapy. Selvester score cutoff points of 5 for were calculated to estimate ICD therapy, with a sensitivity of 100% and specifity of 81%.
CONCLUSION
In our study, it was found that a high Selvester score may be a predictor for ICD therapies in patients with DCM. As an inexpensive and non-invasive method, Selvester score can help in the decision-making in these patients.
简介
植入式心脏复律除颤器（ICD）在非缺血性扩张型心肌病（DCM）患者中的获益仍然存在争议。使用心脏磁共振（CMR）研究心室瘢痕组织与 ICD 电击之间关系的研究具有前景。CMR 研究表明，心室瘢痕组织大小与 Selvester 评分存在相关性。有鉴于此，本研究旨在探讨 Selvester 评分与 ICD 治疗之间的潜在关系。
方法
本研究纳入了 2018 年 12 月至 2019 年 10 月期间在门诊接受 ICD 植入诊断为 DCM 且常规接受 6 个月 ICD 控制的 48 例患者。比较了接受 ICD 治疗（n=10）和未接受 ICD 治疗（n=38）患者的 Selvester 评分和其他数据。
结果
ICD 治疗组的 Selvester 评分（P<0.001）较高。ICD 电击治疗与 Selvester 评分之间存在正相关（P=0.002，r=0.843）。多元线性回归分析显示，Selvester 评分是 ICD 治疗的独立预测因子（P=0.004）。受试者工作特征曲线分析表明，Selvester 评分（P<0.001）是 ICD 治疗的显著预测因子。计算出 Selvester 评分 5 分的截断值来估计 ICD 治疗，其敏感性为 100%，特异性为 81%。
结论
在本研究中，我们发现高 Selvester 评分可能是 DCM 患者 ICD 治疗的预测因子。作为一种廉价且非侵入性的方法，Selvester 评分有助于这些患者的决策制定。
Zotero 插件